|
In a majority of pathologies and/or surgical procedures, a shift occurs in the hemostasis balance between the prothrombotic and hemorrhagic states, and identifying and monitoring the shift between the two states is important under all these conditions. Furthermore, in some circumstances, being able to control the degree of shift can make a critical difference in outcome -- for example, consider the case of using artificial surface devices, where it is beneficial to keep the patient in a slightly anti-coagulated state.
We provide links here to selected application areas with clinical examples, and for each we:
- explain why the shifts occur
- illustrate the shifts in hemostasis
- show how the TEG® Hemostasis Analyzer detects each of the hemostatic states and identifies the degree of imbalance present.
Armed with this information, and using the TEG-guided Hemostasis and Blood Management strategy, clinicians can make better diagnostic and therapeutic decisions.
The following schematic shows a representative tracing obtained from the TEGŪ hemostasis analyzer. It shows both coagulation and fibrinolysis as it occurs in a whole blood sample. The schematic is labeled with the test names that the TEGŪ analyzer reports, and links the test names to the major physiological component being evaluated. For a comprehensive look at the TEGŪ technology and sample results, click here.
|
